eGain Corporation (EGAN) confirmed earnings release on September 03, 2026, After the market for the quarter ending June 30, 2026.The estimated EPS is $0.04The estimated revenue is $21747000 Price Impact of Stock Earnings Earnings Surprise Potential: If the actual earnings exceed market expectations, it could trigger a positive response from investors, leading to buying activity...
Duluth Holdings Inc. (DLTH) confirmed earnings release on September 03, 2026, Before the market for the...
Mama's Creations, Inc. (MAMA) confirmed earnings release on September 03, 2026, After the market for the...
VersaBank (VBNK) confirmed earnings release on September 03, 2026, Before the market for the quarter ending...
Barnes & Noble Education, Inc. (BNED) confirmed earnings release on September 03, 2026, Before the market...
Laurence Alexander from Jefferies issued a price target of $26.00 for IPX on 2026-09-02 07:39:00.The adjusted price target was set to $26.00.At the time of the announcement, IPX was trading...
from Raymond James issued a price target of $87.00 for CHMG on 2026-09-01 20:15:15.The adjusted price target was set to $87.00.At the time of the announcement, CHMG was trading at...
from Lake Street issued a price target of $10.00 for XAIR on 2026-09-01 12:41:46.The adjusted price target was set to $10.00.At the time of the announcement, XAIR was trading at...
Salim Syed from Mizuho Securities issued a price target of $53.00 for ASMB on 2026-09-01 11:41:57.The adjusted price target was set to $53.00.At the time of the announcement, ASMB was...
Edward Nash from Canaccord Genuity issued a price target of $10.00 for ACRS on 2026-09-01 10:21:48.The adjusted price target was set to $10.00.At the time of the announcement, ACRS was...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
